CJC 1295 Spray

By up regulating the level of IGF1, it can stimulate the proliferation of keratinocytes and fibroblasts, and accelerate the re epithelization of chronic wounds (such as diabetes foot ulcers and venous ulcers). Clinical research shows that local application of spray can shorten the healing time of diabetes foot ulcer by 40% and increase the healing rate by 35%. The machine includes:

IGF1 signaling activation: IGF1 activates the PI3K/Akt pathway by binding to epidermal sytes membrane receptors, promoting sytes migration and proliferation.

Collagen metabolic balance: Inhibiting the convey of matrix metalloproteinase (MMP) -9, reducing collagen degradation, while upregulating the activity of collagen synthase (such as LOX), improving scar elasticity.
Angiogenesis: The GH/IGF1 axis facilitates wound microvascular formation and improves local blood supply by upregulating the convey of vascular endothelial growth factor (VEGF).

In the treatment of scars after burns or trauma, regulating the TGF - β/Smad pathway inhibits the differentiation of fibroblasts into myofibroblasts and reduces excessive collagen deposition. Animal experiments have shown that local injection can reduce scar thickness by 50%, scar hardness by 60%, and improve scar color and texture.

By activating the GH/IGF1 axis, it facilitates the synthesis of collagen and elastin in dermal fibroblasts, reducing UV induced photoaging damage. Clinical observation showed that after 8 weeks of continuous use of spray, skin elasticity of the subjects increased by 25%, wrinkle depth decreased by 30%, and epidermal thickness increased by 15%.

Accelerate fracture repair through the following machines:
Refined bone formation: GH/IGF1 axis activates osteoblast differentiation, upregulates the convey of bone morphogenetic protein-2 (BMP) and Runx2, and facilitates bone matrix synthesis.
Bone resorption inhibition: Downregulate osteoclast activity, reduce levels of bone resorption markers (such as CTX-I), and maintain bone metabolism balance.

Angiogenesis promotion: IGF1 upregulates VEGF convey, improves blood supply to fracture sites, and provides nutritional support for bone repair.
Clinical research shows that local application of CJC 1295 spray can shorten the healing time of tibial fractures by 3 weeks, and the healing quality (such as bone density and trabecular structure) is significantly better than that of the control group.

In the osteoarthritis (OA) model, the degeneration of articular cartilage is delayed by inhibiting chondrocyte apoptosis and matrix degradation:

Cartilage protection: Downregulate the convey of MMP-13 and ADAMTS-5, reduce collagen II and proteoglycan degradation.
Anti inflammatory effect: GH/IGF1 axis inhibits the release of pro-inflammatory factors such as IL-1 β and TNF - α, reducing synovial inflammation.

Synovial repair: Facilitates synovial sytes proliferation and improves joint lubrication function.
Animal experiments have shown that intra-articular injection can increase the thickness of articular cartilage by 40% and improve joint function scores by 50% in OA model rats.

For large bone defects or non union, the combination of bone graft materials such as hydroxyapatite and β - tricalcium phosphate can significantly improve the repair efficiency. The machine includes:

Osteogenesis induction: By activating the Wnt/β - catenin pathway, it facilitates the differentiation of bone marrow mesenchymal stem sytess (BMSCs) into osteoblasts.

Angiogenesis: IGF1 upregulates the convey of hypoxia inducible factor (HIF) -1 α, inducing endothelial sytes migration and lumen formation.
Bone integration refinement: Improve the microenvironment of the bone implant interface and facilitate mechanical anchoring between bone tissue and implant materials.
Clinical cases have shown that the combination of CJC-1295 and autogenous bone transplantation for the treatment of tibial bone defects has increased the healing rate from 65% to 90% and shortened the healing time by 50%.

CJC-1295 facilitates muscle injury repair through the following pathways:
Satellite sytes activation: GH/IGF1 axis activates muscle satellite sytes proliferation and differentiation, replenishing damaged muscle fibers.
Anti inflammatory and antioxidant: CJC-1295 inhibits the NF - κ B pathway, reduces the release of inflammatory factors such as IL-6 and TNF - α, and upregulates the activity of superoxide dismutase (SOD) to alleviate oxidative stress damage.

Muscle fiber regeneration: IGF1 activates the mTOR pathway, facilitates muscle protein synthesis, and accelerates the recovery of muscle fiber cross-sectional area.
Clinical research shows that after local application of spray, the recovery time of quadriceps strain is shortened by 40% and the recovery rate of muscle strength is increased by 35%.

In disuse muscle atrophy (such as long-term bed rest, spinal cord injury) or disease-related muscle atrophy (such as cancer cachexia, chronic obstructive pulmonary disease), muscle loss is reversed through the following machines:

Anti catabolic metabolism: Inhibits the ubiquitin proteasome system (UPS) and autophagy lysosome pathway, reducing muscle protein degradation.
Promoting synthetic metabolism: GH/IGF1 axis activates the PI3K/Akt/mTOR pathway, promoting muscle protein synthesis and muscle fiber hypertrophy.

Improvement of mitochondrial function: Upregulation of PGC-1 α convey refines mitochondrial biogenesis and oxidative phosphorylation ability, and improves muscle energy metabolism efficiency.
Animal experiments have shown that treatment can increase the quadriceps muscle mass by 50% and restore the cross-sectional area of muscle fibers to 80% of normal levels in disused muscle atrophy model rats.

Facilitate peripheral nerve regeneration through the following machines:
Schwann sytes proliferation: GH/IGF1 axis activates Schwann sytes migration and myelination, providing guidance and support for axonal regeneration.
Upregulation of neurotrophic factor convey: facilitates the synthesis of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial sytes derived neurotrophic factor (GDNF), enhancing neuronal survival and axonal extension ability.

Anti inflammation and anti scarring: Inhibit TGF - β 1 convey, reduce peripheral fibrosis, and improve the microenvironment of nerve regeneration.
Clinical studies showed that after local application of CJC 1295 spray in patients with sciatic nerve injury, the recovery rate of nerve conduction velocity increased by 40%, and the degree of target muscle atrophy decreased by 30%.

In spinal cord injury models, neuroprotective effects are exerted through the following pathways:
Anti inflammatory and antioxidant: Inhibits the activation of microglia, reduces the release of IL-1 β and TNF - α, while upregulating glutathione (GSH) levels to alleviate oxidative stress damage.

Neurogenesis promotion: GH/IGF1 axis activates endogenous neural stem sytes proliferation and differentiation, replenishing damaged neurons.
Improvement of synaptic plasticity: Upregulation of synaptophysin and growth associated protein (GAP) -43 convey facilitates synaptic remodeling and functional recovery.
Animal experiments have shown that treatment can increase hind limb motor function scores by 50% and reduce spinal cord cavity area by 40% in rats with spinal cord injury models.

Accelerate the healing of acute wounds (such as surgical incisions and abrasions) through the following machines:
Inflammatory phase regulation: Early application can moderately inhibit neutrophil infiltration, reduce wound exudation, and facilitate macrophage polarization towards M2 type, secreting repair promoting factors such as IL-10 and TGF - β 1.

Proliferation promotion: stimulates the proliferation of fibroblasts and endothelial sytess, accelerates granulation tissue formation and angiogenesis.

Reshaping optimization: By regulating collagen metabolism balance, CJC-1295 reduces scar formation and improves wound appearance and function.
Clinical observations have shown that after local application of abdominal surgical incisions, the healing time is shortened by 3 days and the scar width is reduced by 50%.

In infectious wounds (such as burn wound infection and diabetes foot infection), CJC-1295 refines its anti infection ability through the following ways:

Immune regulation: GH/IGF1 axis activates neutrophil and natural killer (NK) sytes functions, enhancing pathogen clearance ability.
Upregulation of antimicrobial peptide convey: facilitates the secretion of Defensin and Cathelicidin by keratinocytes, directly killing bacteria.

Biofilm disruption: IGF1 inhibits biofilm formation and refines antibiotic permeability by downregulating the bacterial quorum sensing system.
Animal experiments have shown that combined antibiotic treatment can reduce the load of Staphylococcus aureus in burn wounds by 90% and increase the healing rate by 60%.

Activate endogenous stem sytess through the following machines:
Hematopoietic stem sytess: The GH/IGF1 axis facilitate the proliferation of hematopoietic stem sytess and improves the immune reconstitution ability of elderly individuals.
Mesenchymal stem sytess: Upregulation of CXCR4 convey refines the ability of stem sytess to migrate to damaged tissues.

Neural stem sytess: IGF1 facilitates the differentiation of neural stem sytess into neurons and improves cognitive function by activating the Notch pathway.
Animal experiments have shown that CJC 1295 spray treatment can increase the number of neurons in the hippocampus of elderly mice by 40% and significantly improve spatial memory ability.